ALB and neoplasm: In contrast, after conversion therapy, none of the tested parameters was significantly associated with 1−year recurrence: tumor size (OR = 1.062, 95% CI: 0.896–1.260, P = 0.488), AST (OR = 1.008, 95% CI: 0.994–1.022, P = 0.273), albumin (OR = 0.976, 95% CI: 0.871–1.094, P = 0.679), and WBC count (OR = 1.025, 95% CI: 0.989–1.062, P = 0.182) (Table 2).